- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Trump: Fed Chair Nominee Confirmed
Yearn Finance Suspected of Attack, Hacker Sends 1,000 ETH of Stolen Funds to Tornado Cash
Ethereum Falls Below $3,000, 24-hour Loss of 0.25%
This Week's Key Events & Data Preview: Powell Speech, US PCE, and ADP Nonfarm Payrolls
Entity: The AI sector is currently at a relatively low risk of overcrowding, with long-term opportunities still present
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App